Suppr超能文献

纳米级磁性核壳和整体分子印迹聚合物用于选择性从人血浆中提取胺碘酮。

Nano-sized magnetic core-shell and bulk molecularly imprinted polymers for selective extraction of amiodarone from human plasma.

机构信息

Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Anal Chim Acta. 2022 Mar 15;1198:339548. doi: 10.1016/j.aca.2022.339548. Epub 2022 Jan 28.

Abstract

Bulk and magnetic core-shell Molecularly Imprinted Polymers (MMIPs) have been introduced and compared to extract and determine amiodarone from a complex matrix, i.e., plasma, due to the importance of Therapeutic Drug Monitoring (TDM). Polymer synthesis was confirmed by FTIR, AFM, TGA, DLS, VSM, TEM, and the adsorption studies such as capacity, isothermal models, selectivity, and regeneration were performed to evaluate and compare polymer efficiency in extraction and separation of amiodarone from sample solutions and human plasma. Both nano-sized and bulk polymers successfully extracted the target molecule at the low therapeutic ranges and the overdose concentrations (recoveries of 98.38%-102.70%). The maximum adsorption capacity of the MMIPs was 42.5 μg/mg compared with 2.6 μg/mg for bulk polymers. The imprinting factors of the polymers were 15.12 and 6.84 for MMIPs and bulk, respectively. MMIPs and bulk polymers presented 4.68 and 1.66 selectivity factors, respectively, towards amiodarone compared with lidocaine. LOD, LOQ, and enrichment factor in human plasma were 0.09, 0.28 μg mL, and 10 respectively. Recoveries of therapeutic concentration from plasma were 91.38 and 97.33% for bulk and MMIPs, respectively. MMIPs as an adsorbent in amiodarone extraction from plasma offered reduced necessary sample amount, less adsorbent consumption, reduced pretreatment time, and reduced elution solvent waste while yielding higher extraction recovery and more specificity for the target compared with the bulk polymer. Bulk polymers have a more straightforward synthesis procedure due to fewer synthesis steps and fewer variables, and Molecularly Imprinted Polymer Solid-phase Extraction (MIP-SPE) has already been introduced commercially. MMIPs prevail on a small scale, and in the context of a simple extraction, separation, or concentration in large-scale bioanalysis, efforts towards optimization and development of MMIPs can unearth tremendous opportunities for green chemistry principles.

摘要

介孔和磁性核壳结构分子印迹聚合物(MMIPs)已被引入并用于从复杂基质(如血浆)中提取和测定胺碘酮,这是因为治疗药物监测(TDM)的重要性。通过 FTIR、AFM、TGA、DLS、VSM、TEM 对聚合物的合成进行了确认,并进行了吸附研究,如容量、等温模型、选择性和再生,以评估和比较聚合物在从样品溶液和人血浆中提取和分离胺碘酮方面的效率。纳米级和块状聚合物都成功地在低治疗范围和过量浓度下提取了目标分子(回收率为 98.38%-102.70%)。MMIPs 的最大吸附容量为 42.5μg/mg,而块状聚合物为 2.6μg/mg。聚合物的印迹因子分别为 MMIPs 为 15.12,块状聚合物为 6.84。与利多卡因相比,MMIPs 和块状聚合物对胺碘酮的选择性因子分别为 4.68 和 1.66。在人血浆中,LOD、LOQ 和富集因子分别为 0.09、0.28μg mL 和 10。从血浆中提取治疗浓度的回收率分别为 91.38%和 97.33%,对于块状聚合物和 MMIPs 而言。与块状聚合物相比,MMIPs 作为从血浆中提取胺碘酮的吸附剂,具有减少所需样品量、减少吸附剂消耗、减少预处理时间和减少洗脱溶剂浪费的优点,同时获得更高的提取回收率和更高的特异性。由于合成步骤较少且变量较少,块状聚合物的合成过程更为简单,而且分子印迹聚合物固相萃取(MIP-SPE)已经商业化。MMIPs 在小规模上占优势,在大规模生物分析中,简单的提取、分离或浓缩方面,努力优化和开发 MMIPs 可以为绿色化学原则带来巨大的机会。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验